The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Curcumin: A new candidate for melanoma therapy?
Abstract
Melanoma remains among the most lethal cancers and, in spite of great attempts that have been made to increase the life span of patients with metastatic disease, durable and complete remissions are rare. Plants and plant extracts have long been used to treat a variety of human conditions; however, in many cases, effective doses of herbal remedies are associated with serious adverse effects. Curcumin is a natural polyphenol that shows a variety of pharmacological activities including anti‐cancer effects, and only minimal adverse effects have been reported for this phytochemical. The anti‐cancer effects of curcumin are the result of its anti‐angiogenic, pro‐apoptotic and immunomodulatory properties. At the molecular and cellular level, curcumin can blunt epithelial‐to‐mesenchymal transition and affect many targets that are involved in melanoma initiation and progression (e.g., BCl2, MAPKS, p21 and some microRNAs). However, curcumin has a low oral bioavailability that may limit its maximal benefits. The emergence of tailored formulations of curcumin and new delivery systems such as nanoparticles, liposomes, micelles and phospholipid complexes has led to the enhancement of curcumin bioavailability. Although in vitro and in vivo studies have demonstrated that curcumin and its analogues can be used as novel therapeutic agents in melanoma, curcumin has not yet been tested against melanoma in clinical practice. In this review, we summarized reported anti‐melanoma effects of curcumin as well as studies on new curcumin formulations and delivery systems that show increased bioavailability. Such tailored delivery systems could pave the way for enhancement of the anti‐melanoma effects of curcumin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543 · cited 1×
“Several studies have reported low or undetectable plasma/tissue levels of free curcumin.(46,47) However, it must be taken into account the metabolites and degradation products of curcumin, like curcumin sulfate, curcumin glucuronide and tetrahydrocurcumin possess significant and, in some cases, similar or stronger bio…”
BackgroundAggarwal, B. B., & Harikumar, K. B. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 1,716
Sharma, R. A., Gescher, A. J., & Steward, W. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.05.009 · Cited by 1,658
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,572
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
Miller, A. J., & Mihm, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052166 · Cited by 1,339
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, I. K., Rajasekharan, K. N., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.008 · Cited by 1,205
Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.1.2 · Cited by 1,057
MicroRNAs and Cancer: Short RNAs Go a Long Way
Ventura, A., & Jacks, T. (2009) · Cell · doi:10.1016/j.cell.2009.02.005 · Cited by 891
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
Schickel, R., Boyerinas, B., Park, S.-M., & Peter, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.274 · Cited by 719
Curcumin: Getting Back to the Roots
SHISHODIA, S., SETHI, G., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.010 · Cited by 715
Curcumin Extract for Prevention of Type 2 Diabetes
Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C., & Jirawatnotai, S. (2012) · Diabetes Care · doi:10.2337/dc12-0116 · Cited by 635
Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M., & Sahebkar, A. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.12.019 · Cited by 406
Self-citationBush, J. A., Cheung, K.-J. J., & Li, G. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5381 · Cited by 385
Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
Improving the Solubility and Pharmacological Efficacy of Curcumin by Heat Treatment
Kurien, B. T., Singh, A., Matsumoto, H., & Scofield, R. H. (2007) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2007.064 · Cited by 350
Burgos‐Morón, E., Calderón‐Montaño, J. M., Salvador, J., Robles, A., & López‐Lázaro, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.24967 · Cited by 336
Gray, E. S., Rizos, H., Reid, A. L., Boyd, S. C., Pereira, M. R., Lo, J., Tembe, V., Freeman, J., Lee, J. H. J., Scolyer, R. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5788 · Cited by 336
Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
B. Mythri, R., & M. Srinivas Bharath, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798918995 · Cited by 323
Chen, Y., Wu, Q., Zhang, Z., Yuan, L., Liu, X., & Zhou, L. (2012) · Molecules · doi:10.3390/molecules17055972 · Cited by 316
Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double‐Blind Placebo‐Controlled Trial
Panahi, Y., Rahimnia, A., Sharafi, M., Alishiri, G., Saburi, A., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5174 · Cited by 310
Self-citationKidd, P. M. (2009) · PubMed · Cited by 304
Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5045 · Cited by 303
Self-citationCytotoxicity, antioxidant and anti-inflammatory activities of Curcumins I–III from Curcuma longa
Ramsewak, R. S., DeWitt, D. L., & Nair, M. G. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80048-3 · Cited by 302
Ferulic acid and its therapeutic potential as a hormetin for age-related diseases
Barone, E., Calabrese, V., & Mancuso, C. (2009) · Biogerontology · doi:10.1007/s10522-008-9160-8 · Cited by 296
Mancuso, C. (2007) · Frontiers in Bioscience · doi:10.2741/2130 · Cited by 294
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer
Yallapu, M. M., Khan, S., Maher, D. M., Ebeling, M. C., Sundram, V., Chauhan, N., Ganju, A., Balakrishna, S., Gupta, B. K., Zafar, N., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.040 · Cited by 290
Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route
Mangalathillam, S., Rejinold, N. S., Nair, A., Lakshmanan, V.-K., Nair, S. V., & Jayakumar, R. (2012) · Nanoscale · doi:10.1039/c1nr11271f · Cited by 280
Mohammadi, A., Sahebkar, A., Iranshahi, M., Amini, M., Khojasteh, R., Ghayour‐Mobarhan, M., & Ferns, G. A. (2013) · Phytotherapy Research · doi:10.1002/ptr.4715 · Cited by 277
Self-citationAggarwal, B., Deb, L., & Prasad, S. (2014) · Molecules · doi:10.3390/molecules20010185 · Cited by 267
Calabrese, V., Guagliano, E., Sapienza, M., Panebianco, M., Calafato, S., Puleo, E., Pennisi, G., Mancuso, C., Allan Butterfield, D., & Stella, A. G. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9203-y · Cited by 241
Philip, S., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207309200 · Cited by 240
Siwak, D. R., Shishodia, S., Aggarwal, B. B., & Kurzrock, R. (2005) · Cancer · doi:10.1002/cncr.21216 · Cited by 236
Panahi, Y., Khalili, N., Hosseini, M. S., Abbasinazari, M., & Sahebkar, A. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.07.006 · Cited by 231
Self-citationPanahi, Y., Alishiri, G. H., Parvin, S., & Sahebkar, A. (2016) · Journal of Dietary Supplements · doi:10.3109/19390211.2015.1008611 · Cited by 227
Self-citationYe, M., Zhang, J., Zhang, J., Miao, Q., Yao, L., & Zhang, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.028 · Cited by 219
Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds
Menon, L. G., Kuttan, R., & Kuttan, G. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03887-3 · Cited by 218
Ma, Z., Haddadi, A., Molavi, O., Lavasanifar, A., Lai, R., & Samuel, J. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31584 · Cited by 206
Panahi, Y., Saadat, A., Beiraghdar, F., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5149 · Cited by 204
Self-citationToxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys.
Shankar, T. N., Shantha, N. V., Ramesh, H. P., Murthy, I. A. S., & Murthy, V. S. (1980) · PubMed · Cited by 201
Esmaily, H., Sahebkar, A., Iranshahi, M., Ganjali, S., Mohammadi, A., Ferns, G., & Ghayour-Mobarhan, M. (2015) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-015-2160-z · Cited by 192
Self-citationPanahi, Y., Ghanei, M., Hajhashemi, A., & Sahebkar, A. (2016) · Journal of Dietary Supplements · doi:10.3109/19390211.2014.952865 · Cited by 192
Self-citationPanahi, Y., Badeli, R., Karami, G., & Sahebkar, A. (2015) · Phytotherapy Research · doi:10.1002/ptr.5211 · Cited by 186
Self-citationZhang, J., Tang, Q., Xu, X., & Li, N. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.021 · Cited by 184
Sahebkar, A., Mohammadi, A., Atabati, A., Rahiman, S., Tavallaie, S., Iranshahi, M., Akhlaghi, S., Ferns, G. A., & Ghayour‐Mobarhan, M. (2013) · Phytotherapy Research · doi:10.1002/ptr.4952 · Cited by 183
Self-citationMicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
Mirzaei, H., Gholamin, S., Shahidsales, S., Sahebkar, A., Jaafari, M. R., Mirzaei, H. R., Hassanian, S. M., & Avan, A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.10.009 · Cited by 182
Self-citationPanahi, Y., Sahebkar, A., Parvin, S., & Saadat, A. (2012) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012040 · Cited by 176
Self-citationPanahi, Y., Sahebkar, A., Amiri, M., Davoudi, S. M., Beiraghdar, F., Hoseininejad, S. L., & Kolivand, M. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511006544 · Cited by 173
Self-citationCurcuminoids for the management of hypertriglyceridaemia
Sahebkar, A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.140-c1 · Cited by 172
Self-citationSahebkar, A. (2013) · BioFactors · doi:10.1002/biof.1062 · Cited by 170
Self-citationMolecular mechanisms for curcumin benefits against ischemic injury
Sahebkar, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.07.1071 · Cited by 168
Self-citationHasan, S. T., Zingg, J.-M., Kwan, P., Noble, T., Smith, D., & Meydani, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.016 · Cited by 162
Curcumin and the cellular stress response in free radical‐related diseases
Calabrese, V., Bates, T. E., Mancuso, C., Cornelius, C., Ventimiglia, B., Cambria, M. T., Di Renzo, L., De Lorenzo, A., & Dinkova‐Kostova, A. T. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700316 · Cited by 158
Skin regenerative potentials of curcumin
Thangapazham, R. L., Sharad, S., & Maheshwari, R. K. (2013) · BioFactors · doi:10.1002/biof.1078 · Cited by 150
Yang, C. H., Yue, J., Sims, M. M., & Pfeffer, L. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071130 · Cited by 148
In vitro and in vivo anti‐tumoral effect of curcumin against melanoma cells
Odot, J., Albert, P., Carlier, A., Tarpin, M., Devy, J., & Madoulet, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20160 · Cited by 145
Zheng, M., Ekmekçioglu, S., Walch, E. T., Tang, C., & Grimm, E. A. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000129374.76399.19 · Cited by 144
Mahammedi, H., Planchat, E., Pouget, M., Durando, X., Curé, H., Guy, L., Van-Praagh, I., Savareux, L., Atger, M., Bayet‐Robert, M., et al. (2016) · Oncology · doi:10.1159/000441148 · Cited by 144
Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway
Zhang (2010) · Oncology Reports · doi:10.3892/or_00000975 · Cited by 141
Curcumin blocks brain tumor formation
Purkayastha, S., Berliner, A., Fernando, S. S., Ranasinghe, B., Ray, I., Tariq, H., & Banerjee, P. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.066 · Cited by 138
Toden, S., Okugawa, Y., Buhrmann, C., Nattamai, D., Anguiano, E., Baldwin, N. E., Shakibaei, M., Boland, C. R., & Goel, A. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0354 · Cited by 138
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Salarinia, R., Sahebkar, A., Peyvandi, M., Mirzaei, H. R., Jaafari, M. R., Riahi, M. M., Ebrahimnejad, H., Nahand, J. S., Hadjati, J., Asrami, M. O., et al. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666151207110143 · Cited by 134
Self-citationHSP90 as a marker of progression in melanoma
McCarthy, M. M., Pick, E., Kluger, Y., Gould-Rothberg, B., Lazova, R. Z., Camp, R. L., Rimm, D. L., & Kluger, H. M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm545 · Cited by 127
Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives
Karewicz, A., Bielska, D., Łoboda, A., Gzyl-Malcher, B., Bednář, J., Józkowicz, A., Dulak, J., & Nowakowska, M. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.03.059 · Cited by 123
Bill, M. A., Fuchs, J. R., Li, C., Yui, J. C., Bakan, C. E., Benson, D. M., Schwartz, E. B., Abdelhamid, D. S., Lin, J., Hoyt, D. G., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-165 · Cited by 121
Marín, Y. E., Wall, B., Wang, S., Namkoong, J., Martino, J. J., Suh, J., Lee, H. J., Rabson, A. B., Yang, C. S., Chen, S., et al. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282ed3d0e · Cited by 116
Sun, Y., Du, L., Liu, Y., et al. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.039 · Cited by 115
Abusnina, A., Keravis, T. M., Yougbaré, I., Bronner, C., & Lugnier, C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100307 · Cited by 113
van Iersel, M. L. P. S., Ploemen, J.-P. H. T. M., Struik, I., van Amersfoort, C., Keyzer, A. E., Schefferlie, J. G., & van BLADEREN, P. J. (1996) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(96)03739-8 · Cited by 112
Lu, Y., Miao, L., Wang, Y., Xu, Z., Zhao, Y. D., Shen, Y., Xiang, G., & Huang, L. (2015) · Molecular Therapy · doi:10.1038/mt.2015.165 · Cited by 109
Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders
Rukhsana Sultana, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.015 · Cited by 94
Gao, S.-M., Yang, J.-J., Chen, C.-Q., Chen, J.-J., Ye, L., Wang, L.-Y., Wu, J.-B., Xing, C., & Yu, K. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-27 · Cited by 94
Bill, M. A., Bakan, C. E., Benson, D. M., Fuchs, J. R., Young, G. S., & Lesinski, G. B. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0377 · Cited by 94
Curcumin Inhibits Melanogenesis in Human Melanocytes
Tu, C., Lin, M., Lu, S., Qi, X., Zhang, R., & Zhang, Y. (2011) · Phytotherapy Research · doi:10.1002/ptr.3517 · Cited by 93
Zhang, P., Bai, H., Liu, G., Wang, H., Chen, F., Zhang, B., Zeng, P., Wu, C., Peng, C., Huang, C., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.02.018 · Cited by 90
Bakhshi, J., Weinstein, L. A., Poksay, K. S., Nishinaga, B., Bredesen, D. E., & Rao, R. V. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0221-x · Cited by 89
Jiang, A., Jiang, G., Li, L., & Zheng, J. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3769-2 · Cited by 88
Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model
Chakraborty, G., Kumar, S., Mishra, R., Patil, T. V., & Kundu, G. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033633 · Cited by 87
Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells
Banerji, A., Chakrabarti, J. L., Mitra, A., & Chatterjee, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.02.007 · Cited by 87
Qiu, Y., Yu, T., Wang, W., Pan, K., Shi, D., & Sun, H. Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.024 · Cited by 87
Wang, L., Shen, Y., Song, R., Sun, Y., Xu, J., & Xu, Q. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059105 · Cited by 87
Chatterjee, S. J., & Pandey, S. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.13798 · Cited by 86
Novel dipeptide nanoparticles for effective curcumin delivery
Chauhan, V. S., Alam, & Panda (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33015 · Cited by 86
Gholamin, S., Pasdar, A., Khorrami, M. S., Mirzaei, H., Mirzaei, H. R., Salehi, R., Ferns, G. A., Ghayour‐Mobarhan, M., & Avan, A. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612822666151112151924 · Cited by 85
Self-citationBill, M. A., Nicholas, C., Mace, T. A., Etter, J. P., Li, C., Schwartz, E. B., Fuchs, J. R., Young, G. S., Lin, L., Lin, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040724 · Cited by 84
Combined effects of GSTP1 and MRP1 in melanoma drug resistance
Depeille, P., Cuq, P., Passagne, I., Evrard, A., & Vian, L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602681 · Cited by 82
Chen, L.-X., He, Y.-J., Zhao, S.-Z., Wu, J.-G., Wang, J.-T., Zhu, L.-M., Lin, T.-T., Sun, B., & Li, X.-R. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.13842 · Cited by 82
Sun, A., Shoji, M., Lu, Y., Liotta, D. C., & Snyder, J. P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051141k · Cited by 80
Cytotoxic activities of phytochemicals from Ferula species
Valiahdi, S. M., Iranshahi, M., & Sahebkar, A. (2013) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-21-39 · Cited by 78
Self-citationKurien, B. T., & Scofield, R. H. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.09.034 · Cited by 77
Waghela, B. N., Sharma, A., Dhumale, S., Pandey, S. M., & Pathak, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117526 · Cited by 76
Depeille, P., Cuq, P., Mary, S., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.897 · Cited by 75
Curcumin in clinical practice: myth or reality?
Mancuso, C., & Barone, E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.004 · Cited by 74
Park, S. Y., JIN, M. L., Kim, Y. H., Kim, Y., & Lee, S.-J. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1155-7 · Cited by 72
Sahebkar, A. (2014) · Natural Product Research · doi:10.1080/14786419.2014.956212 · Cited by 69
Self-citationSynergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin
Chen, J., Li, L., Su, J., Li, B., Chen, T., & Wong, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101277 · Cited by 68
Dahmke, I. N., Backes, C., Rudzitis‐Auth, J., Laschke, M. W., Leidinger, P., Menger, M. D., Meese, E. U., & Mahlknecht, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081122 · Cited by 68
Diet, MicroRNAs and Prostate Cancer
Saini, S., Majid, S., & Dahiya, R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0086-x · Cited by 68
Induction of MicroRNA-9 Mediates Cytotoxicity of Curcumin Against SKOV3 Ovarian Cancer Cells
Zhao, S.-F., Zhang, X., Zhang, X., Shi, X., Yu, Z., & Kan, Q. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3363 · Cited by 66
Zhang, Y. P., Li, Y., Lv, Y. T., & Wang, J. M. (2015) · Genetics and Molecular Research · doi:10.4238/2015.february.6.9 · Cited by 62
Goodpasture, C., & Arrighi, F. E. (1976) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(76)80356-2 · Cited by 58
Prakash, M., Kale, S., Ghosh, I., Kundu, G. C., & Datta, K. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.04.009 · Cited by 58
Multifunctional Albumin Nanoparticles As Combination Drug Carriers for Intra‐Tumoral Chemotherapy
Cui, M., Naczynski, D. J., Zevon, M., Griffith, C. K., Sheihet, L., Poventud‐Fuentes, I., Chen, S., Roth, C. M., & Moghe, P. V. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200467 · Cited by 58
Gao, W., Chan, J. Y. W., & Wong, T. (2014) · Clinical Science · doi:10.1042/cs20140010 · Cited by 56
Pisano, M., Pagnan, G., Dettori, M. A., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-137 · Cited by 55
Zhao, Y., Lin, D., Wu, F., Guo, L., He, G., Ouyang, L., Song, X., Huang, W., & Li, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017565 · Cited by 54
Lipid Lowering Effect of Punica granatum L. Peel in High Lipid Diet Fed Male Rats
Sadeghipour, A., Eidi, M., Kavgani, A. I., Ghahramani, R., Shahabzadeh, S., & Anissian, A. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/432650 · Cited by 54
Liang, H.-H., Wei, P., Hung, C., Wu, C. T., Wang, W., Huang, M. T., & Chang, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-0891-z · Cited by 50
Yu, T., Li, J., Qiu, Y., & Sun, H. Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1086-9 · Cited by 50
Michel, D. L., Chitanda, J. M., Balogh, R., Yang, P., Singh, J., Das, U., El‐Aneed, A., Dimmock, J. R., Verrall, R. E., & Badea, I. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.03.016 · Cited by 49
Loch-Neckel, G., Bubniak, L. D. S., Mazzarino, L., Jacques, A. V., Moccelin, B., Santos‐Silva, M. C., & Lemos‐Senna, E. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24548 · Cited by 48
Jiang, Z., Guo, M., Shi, C., Wang, H., Yao, L., Liu, L., Xie, C., Pu, S.-H., LaChaud, G. Y., Shen, J., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.058 · Cited by 48
Dahmke, I. N., Boettcher, S., Groh, M., et al. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.11.102 · Cited by 48
Synthesis and biological evaluation of novel ferrocenyl curcuminoid derivatives
Arezki, A., Chabot, G. G., Quentin, L., et al. (2011) · MedChemComm · doi:10.1039/c0md00231c · Cited by 48
Miyagawa, T., Saito, H., Minamiya, Y., Mitobe, K., Takashima, S., Takahashi, N., Ito, A., Imai, K., Motoyama, S., & Ogawa, J. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-013-0606-x · Cited by 47
Jiang, G., Xie, W., Wang, H., Du, J., Bai-ping, W., Xu, W., Liu, H., Xiao, P., Liu, Z.-G., Li, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4577 · Cited by 46
Curcumin suppresses α-melanocyte stimulating hormone-stimulated melanogenesis in B16F10 cells
Choi (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000440 · Cited by 46
Curcumin and Alzheimer Disease: This Marriage Is Not to Be Performed
Mancuso, C., Siciliano, R., & Barone, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.l110.133520 · Cited by 45
Curcumin-like diarylpentanoid analogues as melanogenesis inhibitors
Hosoya, T., Nakata, A., Yamasaki, F., Abas, F., Shaari, K., Lajis, N. H., & Morita, H. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0568-0 · Cited by 44
Mazzarino, L., Otsuka, I., Halila, S., Bubniak, L. D. S., Mazzucco, S., Santos‐Silva, M. C., Lemos‐Senna, E., & Borsali, R. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201300465 · Cited by 37
Antimelanoma and Antityrosinase from Alpinia galangal Constituents
Lo, C., Liu, P., Lin, L.-C., Chen, Y., Hseu, Y., Wen, Z., & Wang, H.-M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/186505 · Cited by 36
Development of RGD-Functionalized PEG-PLA Micelles for Delivery of Curcumin
Zhao, L., Yang, C., Dou, J., et al. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.1919 · Cited by 35
Curcumin Induces Cell Death in Human Uveal Melanoma Cells through Mitochondrial Pathway
Lu, C., Song, E., Hu, D., Chen, M., Xue, C., Rosen, R. B., & McCormick, S. A. (2010) · Current Eye Research · doi:10.3109/02713680903521944 · Cited by 35
Visible Light Is a Better Co-Inducer of Apoptosis for Curcumin-Treated Human Melanoma Cells than UVA
Buss, S., Dobra, J., Görg, K., Hoffmann, S., Kippenberger, S., Kaufmann, R., Hofmann, M., & Bernd, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079748 · Cited by 33
Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation
Shakeri, A., & Sahebkar, A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23696 · Cited by 33
Self-citationLow‐Density Lipoprotein is a Potential Target for Curcumin: Novel Mechanistic Insights
Sahebkar, A. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12212 · Cited by 31
Self-citationCurcumin does not switch melanin synthesis towards pheomelanin in B16F10 cells
Wolnicka-Głubisz, A., Nogal, K., Żądło, A. C., & Plonka, P. M. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1523-1 · Cited by 30
Yu, T., Chen, C., Sun, Y., Sun, H. Y., Li, T.-H., Meng, J., & Shi, X. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.144 · Cited by 28
Faião‐Flores, F., Suárez, J. A. Q., Fruet, A. C., Maria–Engler, S. S., Pardi, P. C., & Maria, D. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118702 · Cited by 26
Chemoprevention of skin melanoma: facts and myths
Uzarska, M., Czajkowski, R., Schwartz, R. A., Bajek, A., Zegarska, B., & Drewa, T. A. (2013) · Melanoma Research · doi:10.1097/cmr.0000000000000016 · Cited by 26
Kurien, B. T., Harris, V. M., Quadri, S. M. S., de Souza, P. C., Cavett, J. W., Moyer, A., Ittiq, B., Metcalf, A., Ramji, H. F., Truong, D., et al. (2015) · Lupus Science & Medicine · doi:10.1136/lupus-2015-000114 · Cited by 26
Coupling to a cancer cell‐specific antibody potentiates tumoricidal properties of curcumin
Langone, P., Debata, P. R., Dolai, S., Curcio, G. M., Inigo, J. D. R., Raja, K. S., & Banerjee, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.26479 · Cited by 24
Molecular changes induced by the curcumin analogue D6 in human melanoma cells
Rozzo, C., Fanciulli, M., Fraumene, C., Corrias, A., Cubeddu, T., Sassu, I., Cossu, S., Nieddu, V., Galleri, G., Azara, E., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-37 · Cited by 23
Curcumin does not bind or intercalate into DNA and a note on the gray side of curcumin
Kurien, B. T., Dillon, S. P., Dorri, Y., D’Souza, A., & Scofield, R. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25290 · Cited by 22
The curcumin analog DM-1 induces apoptotic cell death in melanoma
Faião‐Flores, F., Suárez, J. A. Q., Maria–Engler, S. S., et al. (2013) · Tumor Biology · doi:10.1007/s13277-013-0653-y · Cited by 22
The heme oxygenase/biliverdin reductase system: a potential drug target in Alzheimers disease.
Mancuso, C., Santangelo, R., & Calabrese, V. (2014) · PubMed · Cited by 21
Bcl-2 family proteins and cytoskeleton changes involved in DM-1 cytotoxic effect on melanoma cells
Faião‐Flores, F., Suárez, J. A. Q., Soto‐Cerrato, V., Espona‐Fiedler, M., Pérez‐Tomás, R., & Maria, D. A. (2013) · Tumor Biology · doi:10.1007/s13277-013-0666-6 · Cited by 18
Lamoral‐Theys, D., Wauthoz, N., Heffeter, P., Mathieu, V., Jungwirth, U., Lefranc, F., Nève, J., Dubois, J., Dufrasne, F., Amighi, K., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01403.x · Cited by 18
Attaoua, C., Vincent, L., Jaoued, A. A., Hadj‐Kaddour, K., Baï, Q., Vos, J. D., Vian, L., & Cuq, P. (2014) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12093 · Cited by 17
Ruan, B., Lu, X., Li, T., Tang, J.-F., Wei, Y., Wang, X.-L., Zheng, S.-L., Yao, R., & Zhu, H. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.017 · Cited by 17
The Future of Molecular Analysis in Melanoma: Diagnostics to Direct Molecularly Targeted Therapy
Akabane, H., & Sullivan, R. J. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0159-z · Cited by 12
Autophagic activation: A key piece of the puzzle for the curcumin-associated cognitive enhancement?
Sahebkar, A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115620568 · Cited by 12
Self-citation
Cited by
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies
Mirzaei, H., Shakeri, A., Rashidi, B., Jalili, A., Banikazemi, Z., & Sahebkar, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.098 · Cited by 517
Self-citationNLRP3 inflammasome: Its regulation and involvement in atherosclerosis
Hoseini, Z., Sepahvand, F., Rashidi, B., Sahebkar, A., Masoudifar, A., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25930 · Cited by 458
Self-citationImmune modulation by curcumin: The role of interleukin-10
Mollazadeh, H., Cicero, A. F. G., Blesso, C. N., Pirro, M., Majeed, M., & Sahebkar, A. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1358139 · Cited by 381
Self-citationMechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
Mortezaee, K., Salehi, E., Mirtavoos‐mahyari, H., Motevaseli, E., Najafi, M., Farhood, B., Rosengren, R. J., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28122 · Cited by 340
Self-citationAbdollahi, E., Momtazi, A. A., Johnston, T. P., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25778 · Cited by 270
Self-citation
Metadata
- Authors
- Mirzaei, H., Naseri, G., Rezaee, R., Mohammadi, M., Banikazemi, Z., Mirzaei, H. R., Salehi, H., Peyvandi, M., Pawelek, J. M., & Sahebkar, A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2016-07-04
- Volume
- 139
- Issue
- 8
- Pages
- 1683-1695
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2414660052
- Cited by
- 253
- References
- 144
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.